Axon drafted a cooperation agreement between an agro crop improvement company and four other companies, being both shareholders and competitors at the same time.
Updates
Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.
Type (1)
Sectors (2)
Expertises
15 results
Newest first
As a partner of StartLife, Axon assisted a feed company with the regulatory qualification of its technology. Our reasoned opinion serves as a key document for the company’s funding activities.
Axon assisted a start-up developing a real-time diagnostic test to define pathogens food. We negotiated and drafted an agreement with a university to support the further development & validation of the technology.
We have advised a large pharmaceutical company on the conduct of combined studies in collaboration with IVD manufacturers.
We have advised manufacturers, distributors and authorised representatives on all aspects of the IVDR, including assisting a diagnostics manufacturer with the classification and conformity assessment of its in vitro diagnostic medical devices under the new IVDR framework.
We have guided several clients through notified body interactions and discussions with competent authorities on product classification.
We have supported an IVD manufacturer in the design and conduct of performance studies. We regularly advise clients on post-market performance follow-up (PMPF) obligations.
We have assisted multiple manufacturers with the transition of their legacy IVD Directive products to the IVDR framework.
Our team has advised an IVD-manufacturer on use of the inhouse-exemption under the IVDR.
We have advised an IVD manufacturer on a bringing companion diagnostic to market with respect to a patient support program.